文献速递产科母胎医学

产前晚期早产糖皮质激素试验发布后:双胎及孕前糖尿病妊娠呼吸结局的间断时间序列分析

Post Antenatal Late Preterm Steroids trial: interrupted time series analysis of respiratory outcomes in twin and pregestational diabetes.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-06-07

基于美国出生证明数据的回顾性间断时间序列分析,评估产前晚期早产糖皮质激素试验发布后双胎及孕前糖尿病单胎晚期早产儿呼吸结局变化。双胎晚期早产儿即刻辅助通气发生率显著低于试验前趋势预期值(观察11.6% vs 预期13.0%;调整发生率比0.87;95%CI 0.78-0.97),通气超过6小时无显著变化;孕前糖尿病单胎呼吸结局发生率未下降。

要点

  • 双胎晚期早产儿即刻辅助通气发生率观察值11.6%低于预期值13.0%,调整发生率比0.87(95%CI 0.78-0.97)。
  • 双胎晚期早产儿通气超过6小时的发生率在试验发布后无显著变化。
  • 孕前糖尿病单胎晚期早产儿呼吸结局发生率未下降,安慰剂检验提示增加不一定归因于试验发布期。

核心结论

  • 产前晚期早产糖皮质激素试验的发布与美国双胎晚期早产儿即刻辅助通气发生率降低相关,但通气超过6小时无变化。
  • 孕前糖尿病单胎晚期早产儿呼吸结局发生率在试验发布后未降低。

研究设计与样本

  • 回顾性分析美国公开出生证明数据的基于人群的间断时间序列分析。
  • 研究期为2014年8月1日至2018年4月30日,产前晚期早产糖皮质激素试验发布期为2016年2月至2016年10月。
  • 目标人群为无孕前糖尿病的双胎妊娠和合并孕前糖尿病的单胎妊娠,均限于分娩无畸形活产儿且孕周在34 0/7至36 6/7周之间(阴道或剖宫产分娩)。
  • 双胎分析纳入191374例无孕前糖尿病个体,孕前糖尿病单胎分析纳入21395例个体。
  • 敏感性分析在发布期前进行5次、发布期后进行18次,共23次安慰剂检验。

主要发现

  • 双胎晚期早产儿即刻辅助通气发生率观察值11.6% vs 预期值13.0%,调整发生率比0.87(95%CI 0.78-0.97)。
  • 双胎晚期早产儿通气超过6小时的发生率在试验发布后无显著变化。
  • 孕前糖尿病单胎晚期早产儿即刻辅助通气及通气超过6小时的发生率显著增加,但安慰剂检验提示增加不一定归因于试验发布期。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Antenatal Late Preterm Steroids trial found that corticosteroid administration decreased respiratory complications by 20% among late preterm singleton deliveries. After the Antenatal Late Preterm Steroids trial, corticosteroid administration increased by 76% among twin pregnancies and 113% among singleton pregnancies complicated by pregestational diabetes mellitus compared with expected rates based on the pre-Antenatal Late Preterm Steroids trial trend. However, the effect of corticosteroids on twin pregnancies and pregnancies complicated by pregestational diabetes mellitus is not well studied, as the Antenatal Late Preterm Steroids trial excluded twin pregnancies and pregnancies complicated by pregestational diabetes mellitus. OBJECTIVE: This study aimed to examine the change in the incidence rate of immediate assisted ventilation use and ventilation use for more than 6 hours among 2 populations after the dissemination of the Antenatal Late Preterm Steroids trial at the population level. STUDY DESIGN: This study was a retrospective analysis of publicly available US birth certificate data. The study period was from August 1, 2014, to April 30, 2018. The dissemination period of the Antenatal Late Preterm Steroids trial was from February 2016 to October 2016. Population-based interrupted time series analyses were performed for 2 target populations: (1) twin pregnancies not complicated by pregestational diabetes mellitus and (2) singleton pregnancies complicated by pregestational diabetes mellitus. For both target populations, analyses were limited to individuals who delivered nonanomalous live neonates between 34 0/7 and 36 6/7 weeks of gestation (vaginal or cesarean delivery). As a sensitivity analysis, a total of 23 placebo tests were conducted before (5 tests) and after (18 tests) the dissemination period. RESULTS: For the analysis of late preterm twin deliveries, 191,374 individuals without pregestational diabetes mellitus were identified. For the analysis of late preterm singleton pregnancy with pregestational diabetes mellitus, 21,395 individuals were identified. After the dissemination period, the incidence rate of immediate assisted ventilation use for late preterm twin deliveries was significantly lower than the expected value based on the pre-Antenatal Late Preterm Steroids trial trend (11.6% observed vs 13.0% expected; adjusted incidence rate ratio, 0.87; 95% confidence interval, 0.78-0.97). The incidence rate of ventilation use for more than 6 hours among late preterm twin deliveries did not change significantly after the dissemination of the Antenatal Late Preterm Steroids trial. A significant increase in the incidence rate of immediate assisted ventilation use and ventilation use for more than 6 hours was found among singleton pregnancies with pregestational diabetes mellitus. However, the results of placebo tests suggested that the increase in incidence was not necessarily due to the dissemination period of the Antenatal Late Preterm Steroids trial. CONCLUSION: The dissemination of the Antenatal Late Preterm Steroids trial was associated with decreased incidence of immediate assisted ventilation use, but no change in ventilation use for more than 6 hours, among late preterm twin deliveries in the United States. In contrast, the incidence of neonatal respiratory outcomes among singleton deliveries with pregestational diabetes mellitus did not decrease after the dissemination of the Antenatal Late Preterm Steroids trial.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Onishi K, Huang JC, Saade GR, et al. Post Antenatal Late Preterm Steroids trial: interrupted time series analysis of respiratory outcomes in twin and pregestational diabetes. Am J Obstet Gynecol MFM. 2023. PMID: 37290604. doi:10.1016/j.ajogmf.2023.101041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。